-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – U-87 in Pancreatic Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.U-87 in Pancreatic Cancer Drug Details:U-87 is under development for the treatment of pancreatic cancer, lung...
-
Product Insights
![]()
K05-U Field, Netherlands
K05-U upstream field is located in North Sea, Netherlands. The upstream field is owned by EBN BV (50%); Total E&P Netherlands BV (50%). It is operated by Total E&P Netherlands BV. The project started its operations in 2011. K05-U Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and...
-
Product Insights
![]()
U Minh Upstream Project , Vietnam
U Minh upstream project is located in South China Sea, Vietnam. The upstream project is owned by Jadestone Energy Inc. It will be operated by Jadestone Energy Inc. The project is currently in the announced stage and is expected to start operations in 2025. U Minh Upstream profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – U-01 in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.U-01 in Relapsed Acute Myeloid Leukemia Drug Details:U-01 is under development for the treatment of B...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drug Details:Gene therapy is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – U-01 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.U-01 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drug Details:U-01 is under development for...
-
Product Insights
New![]()
Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Urine Analysis Pipeline Market Report Overview Urine analysis refers to the analysis of urine to aid in the diagnosis of disease or to detect the presence of a specific substance. The Urine Analysis pipeline market research report provides comprehensive information about the Urine Analysis pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Urine Analyzers ·       Urine Analyzer Reagents Key Territories ·       ...
-
Product Insights
New![]()
United Kingdom (UK) Pet Insurance Market Dynamics, Trends and Opportunities
United Kingdom (UK) Pet Insurance Market Report Overview The UK pet insurance market size was GBP1.58 billion in 2022. The market is expected to achieve a CAGR of more than 4% during 2022-2027. The market will be primarily driven by rising premiums, which are unavoidable due to the increasing cost of veterinary care. UK Pet Insurance Market Outlook, 2022-2027 (GBP Billion) Buy the Full Report for More Insights into the UK Pet insurance Market Forecast Download a Free Report Sample...
-
Analyst Opinions
New![]()
Taiwan Cards and Payments – Opportunities and Risks to 2027
Taiwan Cards and Payments Market Report Overview The Taiwan cards and payments market size is $139.5 billion in 2023. The market is expected to achieve a CAGR of more than 8% during 2023-2027. A strong banked population, high financial awareness, banks incentivizing customers through a range of benefits (including cashback and discounts), the increasing preference for digital banking, and efforts by financial authorities to boost cashless payments have driven payment card adoption in the country. Taiwan Cards and Payments Market...
-
Product Insights
![]()
Comm Builders/ JP Parcel U – Parcel U Mixed-Use Complex – Massachusetts
Equip yourself with the essential tools needed to make informed and profitable decisions with our Comm Builders/ JP Parcel U - Parcel U Mixed-Use Complex - Massachusetts report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
![]()
u-blox Holding AG – Company Profile
u-blox Holding AG is a Swiss fabless semiconductor provider of embedded positioning and wireless communications solutions. The company operates through two segments, Positioning and Wireless Products, and Wireless Services.
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TAVO-412 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TAVO-412 in Gastric Cancer Drug Details: TAVO-412 is under development for the treatment of advanced...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ET-02 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ET-02 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drug Details: ET-02 is...
-
Product Insights
New![]()
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas. GlobalData's Medical Devices sector report, “Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in...
-
Product Insights
![]()
DIE – BE-U Commercial District Development – Berlin
Equip yourself with the essential tools needed to make informed and profitable decisions with our DIE - BE-U Commercial District Development - Berlin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
![]()
Vikramshila U – University Campus Building – Bihar
Equip yourself with the essential tools needed to make informed and profitable decisions with our Vikramshila U - University Campus Building - Bihar report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
![]()
U Porto – Porto University Expansion – Porto
Equip yourself with the essential tools needed to make informed and profitable decisions with our U Porto - Porto University Expansion - Porto report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
![]()
U and I – Kingstanding Business Park – Kent
Equip yourself with the essential tools needed to make informed and profitable decisions with our U and I - Kingstanding Business Park - Kent report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Patritumab Deruxtecan in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Patritumab Deruxtecan in Triple-Negative Breast Cancer (TNBC) Drug Details: Patritumab deruxtecan (U-31402) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Patritumab Deruxtecan in Metastatic Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Patritumab Deruxtecan in Metastatic Breast Cancer Drug Details: Patritumab deruxtecan (U-31402) is under development for...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.